New reviewer recruitment
Cancer Cell International invites you to join our team of reviewers in assessing manuscripts. For consideration, please send your CV to email@example.com.
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.
We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.
The thematic series is now open for submission of original research and review articles - for further information about this series please click here.
Top reviewers of 2018
A peer-reviewed journal would not survive without the generous time and insightful comments of the reviewers, whose efforts often go unrecognized. Although final decisions are always editorial, they are greatly facilitated by the deeper technical knowledge, scientific insights, understanding of social consequences, and passion that reviewers bring to our deliberations. For these reasons, the Editors and staff of Cancer Cell International would like to publicly acknowledge our top peer reviewers of 2018.
Junfeng Bi, University of California at San Diego, USA
Dongjiang Chen, University of Florida, USA
Jie Ding, M.D. Anderson Cancer Center, USA
Taronish Dubash, Harvard Medical School, USA
Peeyush Goel, University of Pennsylvania, USA
Yu Han, Harbin Medical University, China
Shreya Kulkarni, Rubius Therapeutics, USA
Catherine Lewis, Norton Community Hospital, USA
Hao-yu Lin, Shantou University, China
Shengchen Lin, Penn State University, USA
Chang Liu, University of Rhode Island, USA
Shubhashish Sarkar, University of Texas Medical Branch, USA
Daniele Vergara, University of Salento, Italy
Chong Wang, Harvard Medical School, USA
Zehua Wang, University of Pittsburgh, USA
Go J. Yoshida, Juntendo University, Japan
Chen Zhang, M.D. Anderson Cancer Center, USA
Hui Zhang, Stanford University, USA
Domenico Coppola, Moffitt Cancer Center, USA
Spotlight: Associate Editor
Dr. Krušlin graduated from the University of Zagreb, School of Medicine, Croatia in 1984. He currently works as Head of Department of Pathology and Cytology in Sestre milosrdnice Clinical Hospital Center, Zagreb, as well as Professor of Pathology at the University of Zagreb. Dr. Krušlin deals with routine pathology with special emphasis on urinary tract and male genital system pathology. His research topics include stromal changes, particularly in prostate and urinary bladder cancer and kidney.
Spotlight: Editorial Board
Dr. Chang Liu currently works at the University of Rhode Island. His activities are focused on cancer research with a particular interest in screening small molecules as anti-cancer agents. His research interests also includes investigation of CRIPSR/Cas9 technology and the role of histone methyltransferases in T cell using CRIPSR-based screening.
Annual Journal Metrics
56 days to first decision for reviewed manuscripts only
50 days to first decision for all manuscripts
114 days from submission to acceptance
12 days from acceptance to publication
153 Altmetric mentions